Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Fedratinib bulk supplier for pharma manufacturers

Fedratinib 100mg, 200mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 100mg, 200mg

Reference Brands: Inrebic (USA/EU)

Category: Oncology Cancer Care

Fedratinib is an oral JAK2 inhibitor used for the treatment of adults with intermediate-2 or high-risk primary or secondary myelofibrosis. It helps reduce spleen size and improves disease-related symptoms by selectively targeting the JAK2 pathway involved in abnormal blood cell production.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Fedratinib — third party manufacturing & bulk supply

Fedratinib 100mg, 200mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Fedratinib is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Fedratinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Fedratinib →
Back to Listing

Frequently Asked Questions

Fedratinib is used for treating intermediate-2 or high-risk primary myelofibrosis, post-polycythemia vera myelofibrosis, and post-essential thrombocythemia myelofibrosis. It works as a selective JAK2 inhibitor that helps reduce spleen size and improve associated disease symptoms.

Fedratinib is made from the active ingredient fedratinib hydrochloride, a targeted small-molecule JAK2 inhibitor designed to block dysregulated signaling involved in myeloproliferative disorders.

The trade name is Inrebic.

Inrebic is manufactured and marketed by Celgene, which is now a part of Bristol-Myers Squibb (BMS).

The generic name is fedratinib hydrochloride.

The brand name is Inrebic.

Fedratinib is manufactured in the United States and Europe under Bristol-Myers Squibb’s regulated production facilities.

Related Products

Decitabine + Cedazuridine

Strength:
35 mg + 100mg

Form: Tablets

Reference Brands: Inqovi (USA/EU)

View Details
Imlunestrant Tosylate

Strength:
200 mg

Form: Tablets

Reference Brands: Inluriyo (USA)

View Details
Tarlatamab-Dlle.

Strength:
1 mg, 10 mg

Form: Injection

Reference Brands: Imdelltra (USA), Imdylltra (EU/UK)

View Details
Ixabepilone

Strength:
15 mg, 45mg

Form: Injection

Reference Brands: Ixempra (USA)

View Details
Gilteritinib

Strength:
40 mg

Form: Tablets

Reference Brands: Xospata (USA/India), LuciGil (Asia)

View Details
Panobinostat Lactate

Strength:
10 mg, 15 mg, 20 mg

Form: Capsules

Reference Brands: Farydak (USA/EU),

View Details
Vorinostat

Strength:
100 mg

Form: Capsules

Reference Brands: Zolinza (USA/EU), Vornat (India)

View Details
Fruquin 5 Mg (Fruquintinib)

Strength:
5 Mg

Form: Capsules

Reference Brands: Everest Bangladesh altd.

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.